top
Search terms
Results 1 - 8 of 8 - ordered by :
Escardio

(1-3) Professor Philippe Gabriel Steg, principal investigator of the CLARIFY registry, said: “The optimal blood pressure target in patients with hypertension continues to be debated, especially ...

Date : 30/08/2016
Escardio

The Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT) already published and presented during AHA 20181 randomized 8179 patients with established ...

Date : 06/05/2019
Escardio

EMBARGOED: 23 May 2016 at 08:30 CEST Florence, Italy – 23 May 2016: A subgroup analysis in heart failure patients with diabetes from the ATMOSPHERE trial has failed to show benefit and signals ...

Date : 23/05/2016
Escardio

Long-term use of coal, wood, or charcoal for cooking is associated with an increased risk of death from cardiovascular disease, according to a study presented today at ESC Congress 2018(1). Dr ...

Date : 26/08/2018
Escardio

First randomised trial tests criteria used to diagnose heart attack The Universal Definition of Myocardial Infarction recommends that any increase in troponin above the 99th centile of a healthy ...

Date : 28/08/2018
Escardio

Monitoring platelet function in order to individualize antiplatelet therapy did not improve outcomes for elderly patients after a heart attack compared to a standard, unmonitored approach, results of ...

Date : 28/08/2016
Escardio

The combination of ticagrelor and aspirin reduces ischaemic events compared with aspirin alone in patients with stable coronary artery disease and diabetes. Senior author Professor Deepak L. Bhatt ...

Date : 01/09/2019
Escardio

Up to 50% of patients with ST-segment elevation myocardial infarction (STEMI) have multivessel coronary artery disease. Prior randomised trials found declines in composite outcomes with non-culprit ...

Date : 01/09/2019